PAX5 and leukemia: Similar to leukemias from the delayed Pax5+/− group, early exposure tumors showed recurrent mutations affecting the remaining WT Pax5 allele, with Pax5 p.P80R occurring in 2 out of 4 analyzed leukemias (Supplementary Fig. S7).